Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine

Med Clin (Barc). 2017 Oct 11;149(7):312-313. doi: 10.1016/j.medcli.2017.05.041. Epub 2017 Jul 21.

[Article in English, Spanish]

Authors

Sananda I Moctezuma¹, Carlos M Panizo², Manuel F Landecho³

Affiliations

¹ Departamento de Medicina Interna, Clínica Universitaria de Navarra, Pamplona, Navarra, España. Electronic address: smoctezuma.1@alumni.unav.es.
² Departamento de Hematología, Clínica Universitaria de Navarra, Pamplona, Navarra, España.
³ Departamento de Medicina Interna, Clínica Universitaria de Navarra, Pamplona, Navarra, España.

PMID: 28736065
DOI: 10.1016/j.medcli.2017.05.041

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Azathioprine / therapeutic use*
Common Variable Immunodeficiency / complications
Common Variable Immunodeficiency / drug therapy*
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents / therapeutic use*
Lung Diseases, Interstitial / drug therapy*
Lung Diseases, Interstitial / etiology
Middle Aged
Rituximab / therapeutic use*

Substances

Immunosuppressive Agents
Rituximab
Azathioprine